Arkansas Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Healthcare Report.

Press releases published on June 8, 2026

Jun. 8, 2026

Healthcare Financial Management Association recognizes Dennis Dahlen for contributions to healthcare

Indeterminate GlobeNewswire

Jun. 8, 2026

TOMI Environmental Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets

Indeterminate GlobeNewswire

Jun. 8, 2026

Healthcare Financial Management Association (HFMA) announces Matthew E. Cox as National Chair along with new officers, board members

Indeterminate GlobeNewswire

Jun. 8, 2026

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet

Indeterminate GlobeNewswire

Jun. 8, 2026

America’s Warrior Partnership Strengthens Data-Driven Approach to Serving Veterans Through Approved Evaluation Framework

Indeterminate GlobeNewswire

Jun. 8, 2026

National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada

Indeterminate GlobeNewswire

Jun. 8, 2026

Appel À Une Action Nationale Pour Lutter Contre La Crise De La Douleur Chronique Chez Les Femmes Et Les Vétéranes Au Canada

Indeterminate GlobeNewswire

Jun. 8, 2026

Sharecare to honor extraordinary nurses through The DAISY Foundation’s global recognition program

Indeterminate GlobeNewswire

Jun. 8, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

Indeterminate GlobeNewswire

Jun. 8, 2026

Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease

Indeterminate GlobeNewswire

Jun. 8, 2026

Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1

Indeterminate GlobeNewswire

Jun. 8, 2026

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 8, 2026

Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

Indeterminate GlobeNewswire

Jun. 8, 2026

Medera Expands Scientific Advisory Board with Leading Heart Failure and Cardiopulmonary Physiology Experts to Advance HFpEF Gene Therapy Program

Indeterminate GlobeNewswire

Jun. 8, 2026

Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens

Indeterminate GlobeNewswire

Jun. 8, 2026

Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes

Indeterminate GlobeNewswire

Jun. 8, 2026

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

Indeterminate GlobeNewswire

Jun. 8, 2026

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

Indeterminate GlobeNewswire

Jun. 8, 2026

Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China

Indeterminate GlobeNewswire

Jun. 8, 2026

Rhea's Factory Wins Global Change Award 2026 for AI-Designed Enzymes Enabling Textile-to-Textile Recycling

Indeterminate GlobeNewswire